186 related articles for article (PubMed ID: 24164777)
1. Placebo effect in burning mouth syndrome: a systematic review.
Kuten-Shorrer M; Kelley JM; Sonis ST; Treister NS
Oral Dis; 2014 Apr; 20(3):e1-6. PubMed ID: 24164777
[TBL] [Abstract][Full Text] [Related]
2. Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature.
de Moraes M; do Amaral Bezerra BA; da Rocha Neto PC; de Oliveira Soares AC; Pinto LP; de Lisboa Lopes Costa A
J Oral Pathol Med; 2012 Apr; 41(4):281-7. PubMed ID: 22092585
[TBL] [Abstract][Full Text] [Related]
3. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study.
Carbone M; Pentenero M; Carrozzo M; Ippolito A; Gandolfo S
Eur J Pain; 2009 May; 13(5):492-6. PubMed ID: 18675569
[TBL] [Abstract][Full Text] [Related]
4. The efficiency of alpha-lipoic acid in the treatment of burning mouth syndrome: a systematic review.
Alqahtani SS
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6585-6591. PubMed ID: 34787861
[TBL] [Abstract][Full Text] [Related]
5. World Workshop on Oral Medicine VII: Burning mouth syndrome: A systematic review of disease definitions and diagnostic criteria utilized in randomized clinical trials.
Ariyawardana A; Chmieliauskaite M; Farag AM; Albuquerque R; Forssell H; Nasri-Heir C; Klasser GD; Sardella A; Mignogna MD; Ingram M; Carlson CR; Miller CS
Oral Dis; 2019 Jun; 25 Suppl 1():141-156. PubMed ID: 30785661
[TBL] [Abstract][Full Text] [Related]
6. Place of placebo therapy in the treatment of burning mouth syndrome: A systematic review.
Khemiss M; Chaabouni D; Ben Khaled R; Ben Khélifa M
Dent Med Probl; 2022; 59(4):603-616. PubMed ID: 36548518
[TBL] [Abstract][Full Text] [Related]
7. Burning mouth syndrome: a systematic review of treatments.
Liu YF; Kim Y; Yoo T; Han P; Inman JC
Oral Dis; 2018 Apr; 24(3):325-334. PubMed ID: 28247977
[TBL] [Abstract][Full Text] [Related]
8. Management of burning mouth syndrome: systematic review and management recommendations.
Patton LL; Siegel MA; Benoliel R; De Laat A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S39.e1-13. PubMed ID: 17379153
[TBL] [Abstract][Full Text] [Related]
9. Dopa responsive burning mouth syndrome: restless mouth syndrome or oral variant of restless legs syndrome?
Prakash S; Ahuja S; Rathod C
J Neurol Sci; 2012 Sep; 320(1-2):156-60. PubMed ID: 22819057
[TBL] [Abstract][Full Text] [Related]
10. Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis.
Cui Y; Xu H; Chen FM; Liu JL; Jiang L; Zhou Y; Chen QM
Oral Dis; 2016 Sep; 22(6):503-11. PubMed ID: 26680638
[TBL] [Abstract][Full Text] [Related]
11. Effect of a 2% topical chamomile application for treating burning mouth syndrome: a controlled clinical trial.
Valenzuela S; Pons-Fuster A; López-Jornet P
J Oral Pathol Med; 2016 Aug; 45(7):528-33. PubMed ID: 26694632
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment of burning mouth syndrome: A review and update.
Mínguez Serra MP; Salort Llorca C; Silvestre Donat FJ
Med Oral Patol Oral Cir Bucal; 2007 Aug; 12(4):E299-304. PubMed ID: 17664916
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of randomized trials for the treatment of burning mouth syndrome.
Kisely S; Forbes M; Sawyer E; Black E; Lalloo R
J Psychosom Res; 2016 Jul; 86():39-46. PubMed ID: 27302545
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of treatment modalities in burning mouth syndrome-A systematic review.
Ślebioda Z; Lukaszewska-Kuska M; Dorocka-Bobkowska B
J Oral Rehabil; 2020 Nov; 47(11):1435-1447. PubMed ID: 32979878
[TBL] [Abstract][Full Text] [Related]
15. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology.
Femiano F; Gombos F; Scully C; Busciolano M; De Luca P
Oral Dis; 2000 Sep; 6(5):274-7. PubMed ID: 11002408
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review.
List T; Axelsson S; Leijon G
J Orofac Pain; 2003; 17(4):301-10. PubMed ID: 14737874
[TBL] [Abstract][Full Text] [Related]
17. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.
Femiano F; Scully C
J Oral Pathol Med; 2002 May; 31(5):267-9. PubMed ID: 12110042
[TBL] [Abstract][Full Text] [Related]
18. Burning mouth syndrome: a review and update.
Sun A; Wu KM; Wang YP; Lin HP; Chen HM; Chiang CP
J Oral Pathol Med; 2013 Oct; 42(9):649-55. PubMed ID: 23772971
[TBL] [Abstract][Full Text] [Related]
19. World Workshop in Oral Medicine VII: Reporting of IMMPACT-recommended outcome domains in randomized controlled trials of burning mouth syndrome: A systematic review.
Farag AM; Albuquerque R; Ariyawardana A; Chmieliauskaite M; Forssell H; Nasri-Heir C; Klasser GD; Sardella A; Mignogna MD; Ingram M; Carlson CR; Miller CS
Oral Dis; 2019 Jun; 25 Suppl 1():122-140. PubMed ID: 31140700
[TBL] [Abstract][Full Text] [Related]
20. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies.
Femiano F
Minerva Stomatol; 2002 Sep; 51(9):405-9. PubMed ID: 12473978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
